Summary
Centrally active drugs of the phenothiazine-, butyrophenone- and iminodibenzyl class markedly decreased the rate of dopamine oxidation in the presence of rat brain catecholamine oxidase.
Similar content being viewed by others
References
C. Vander Wende and M. T. Spoerlein, Life Sci.6, 386 (1963).
B. C. Barrass and D. B. Coult, Biochem. Pharmac.22, 2897 (1973).
B. C. Barrass, D. B. Coult, P. Rich and K. J. Tutt, Biochem. Pharmac.23, 47 (1974).
C. Vander Wende, Archs int. Pharmacodyn. Ther.152, 433 (1964).
A. Hoffer and H. Osmond, in: The Chemical Basis of Clinical Psychiatry, p. 39. C. C. Thomas, Springfield 1960.
O. H. Lowry, N. J. Rosebrough, A. L. Farr and R. J. Randall, J. biol. Chem.193, 265 (1951).
M. J. Mercier and P. A. Dumont, J. Pharm. Pharmac.24, 706 (1972).
A. S. Horn and S. H. Snyder, Proc. natn. Acad. Sci. USA68, 2325 (1971).
M. H. J. Koch, Molec. Pharmac.10, 425 (1974).
S. Løvtrup, in: Molecular Basis of Some Aspects of Mental Activity, vol. 2, p. 39. Ed. O. Walaas. Academic Press, London and New York 1967.
S. Løvtrup, J. Neurochem.11 377 (1964).
E. F. Domino, R. D. Hudson and G. Zografi, in: Drugs Affecting the Central Nervous System, vol. 2 p. 327. Ed. A. Burger. Dekker, New York, 1968.
M. H. van Woert, J. Pharmac. exp. Ther.173, 256 (1970).
P. Palatini, Molec. Pharmac.13, 216 (1977).
Author information
Authors and Affiliations
Additional information
The financial support from Gotfred Lie and Marie Lie's Fond is gratefully acknowledged.
Rights and permissions
About this article
Cite this article
Løvstad, R.A. Effect of centrally active drugs on dopamine oxidation by rat brain catecholamine oxidase. Experientia 35, 1642–1644 (1979). https://doi.org/10.1007/BF01953243
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01953243